Short physical performance battery for middle-aged and older adult cardiovascular disease patients: implication for strength tests and lower extremity morphological evaluation
- PMID: 28533623
- PMCID: PMC5430286
- DOI: 10.1589/jpts.29.748
Short physical performance battery for middle-aged and older adult cardiovascular disease patients: implication for strength tests and lower extremity morphological evaluation
Abstract
[Purpose] To examine if the SPPB is higher with healthy subjects than outpatients, which was higher than inpatients and if the SPPB can be validated assessment tool for strength tests and lower extremity morphological evaluation in cardiovascular disease patients. [Subjects and Methods] Twenty-four middle aged and older adults with cardiovascular disease were recruited from inpatient and outpatient facilities and assigned to separate experimental groups. Twelve age-matched healthy volunteers were assigned to a control group. SPPB test was used to assess balance and functional motilities. The test outcomes were compared with level of care (inpatient vs. outpatient), physical characteristics, strength and lower extremity morphology. [Results] Total SPPB scores, strength tests (knee extensor muscle strength), and lower extremity morphological evaluation (muscle thickness of anterior and posterior mid-thigh and posterior lower-leg) were greater in healthy subjects and outpatients groups compared with inpatients. To predict total Short Physical Performance Battery scores, the predicted knee extension and anterior mid-thigh muscle thickness were calculated. [Conclusion] The SPPB is an effective tool as the strength tests and lower extremity morphological evaluation for middle-aged and older adult cardiovascular disease patients. Notably, high knee extensor muscle strength and quadriceps femoris muscle thickness are positively associated with high SPPB scores.
Keywords: Muscle thickness; Quadriceps femoris; SPPB.
References
-
- Ohira T, Iso H: Cardiovascular disease epidemiology in Asia: an overview. Circ J, 2013, 77: 1646–1652. - PubMed
-
- Arpaia G, Bavera PM, Caputo D, et al. : Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study. Thromb Res, 2010, 125: 315–317. - PubMed
-
- Naritomi H, Moriwaki H, Metoki N, et al. MARVELOUS (Muscular Atrophy Restraint with Vigilant Edaravone Long-term Use after Stroke) Study Group: Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study. Drugs R D, 2010, 10: 155–163. - PMC - PubMed
-
- Naritomi H, Moriwaki H: Prevention of post-stroke disuse muscle atrophy with a free radical scavenger. Front Neurol Neurosci, 2013, 32: 139–147. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources